Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > ARLZ will be discounted to cash

<< Previous

Bullboard Posts

Next >>

Comment by AbNormAlon Mar 16, 2017 1:04pm

117 Views

Post# 25988879

RE:RE:RE:RE:RE:RE:RE:RE:ARLZ will be discounted to cash

Just took my punch in the gut. Banked on Adams and Yosprala... oh well, as a friend of mine used to say, "... sometimes you eats the bear and sometimes the bear eats you."

kuatolives wrote: I hope it comes back for the sake of the other shareholders, but my confidence was just shattered. My instincts tell me to get out, so I'm going to listen.

My big fear is that Yosprala won't get adopted beyond a first prescription tryout as the doctor's go "Hey, give this a try," and the patient does, but doesn't renew the script because renewing scripts is a big pain - when you can just go down to the grocery store when you get around to it and pick up some aspirin and omnepezole without a script. Also:

-No confidence in Harris having destroyed his shareholder's capital.
-Deerfield could write off the whole adventure at any time.
-Insider selling
-ARLZ is a one trick pony, and if that pony breaks its leg, it's over.
-Bad blood over Tribute
-Much better personal success on Venture stocks. Heading back there....